January 20, 2021, Paris, France The iHealth Group of Brazil and Medexprim partner to accelerate international clinical research in Brazil, and to boost the identification and the recruitment of patients into clinical trials. The iHealth …
On its five-year anniversary, Medexprim is presenting R-WiDE 2025 (From Real-World Imaging Data to Evidence), its five-year strategic plan. This growth plan aims to accelerate clinical research by: Unleashing imaging and clinical data in clinical …
Romain Cazavan, CEO of Medexprim, spoke with Aïssa Khelifa for DSIH, the French professional magazine devoted to Health IT. The interview was published on December 1, 2020 (read the original French version here). AKH: Hello Romain, …
Medexprim is proud to be the only French startup, as well as the only European Real-World Data and Real-World Evidence company, to have been selected by Euroquity for the Access2EIC – Seal of Excellence e-Pitch …
Medexprim is very proud to start its new collaboration in the H2020 EU CHAIMELEON project. CHAIMELEON aims to set up a structured repository for health imaging data to be openly reused in AI experimentation for …
This summer, Medexprim received the European Commission’s Seal of Excellence for MIDAC (Medical Imaging Data Against Coronavirus), our project submitted to the EIC Accelerator COVID call. MIDAC’s goal was to constitute a centralized, collaborative and …
In this webinar Medexprim and Graticule convened a panel of experts that bridge across geographies and backgrounds to discuss solutions for sharing advanced Real World Data for COVID-19 research. The panel shares their expertise on …
Karine Seymour, founder of Medexprim, hands over the Presidency of the company to Romain Cazavan. She continues to manage the Operations Department and the product management. Medexprim, a hyper-growth company specialized in “big data” in …
